| View |
|
DRP-9986-01
|
Rosuvastatin (as calcium)
|
Mayrosu
|
20 mg
|
Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
08 July 2025
|
| View |
|
HRP-389-01
|
Zinc oxide + Calamine
|
None
|
555.70 mg/164.50 mg per 3.5 gram
|
Ointment
|
Anti-inflammatory/Antipruritic
|
Azine Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 June 2024
|
14 September 2025
|
| View |
|
DRP-8115
|
Hydralazine Hydrochloride
|
Hylazine
|
20 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Antihypertensive (Hydrazinophthalazine Derivative)
|
Unijules Life Sciences Ltd.
|
India
|
Automatic Renewal (Correction)
|
23 June 2021
|
25 May 2025
|
| View |
|
DRP-12276-01
|
Glimepiride
|
None
|
2 mg
|
Tablet
|
Sulfonylurea
|
Amherst Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
21 July 2023
|
09 July 2027
|
| View |
|
DRP-10258
|
Ketorolac Trometamol
|
Fukolac
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
Renewal
|
23 February 2024
|
22 July 2029
|
| View |
|
DRP-9840
|
Hyoscine-N-Butylbromide
|
Hyosaph
|
20mg/mL
|
Solution for Injection (I.M./I.V./S.C.)
|
Anticholinergic / Antispasmodic
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
23 June 2021
|
23 June 2026
|
| View |
|
DRP-5107-03
|
Hydrocortisone (as sodium succinate)
|
Hydrovil
|
100 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Amson Vaccines & Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
05 June 2023
|
24 May 2026
|
| View |
|
DRP-9729-01
|
Fluocinolone Acetonide + Polymyxin B Sulfate + Neomycin Sulfate
|
Otowell
|
250 mcg/10,000 U/3.5 mg per mL
|
Otic Solution
|
Corticosteroid and Anti-infective
|
Pascual Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
04 May 2023
|
30 July 2027
|
| View |
|
DRP-1969-07
|
Amoxicillin (As Trihydrate)
|
Moxed
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
21 March 2023
|
23 February 2026
|
| View |
|
DRP-8727-08
|
Cetirizine Hydrochloride
|
Alleclear
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 July 2024
|
12 February 2025
|
| View |
|
DRP-8727-09
|
Cetirizine Hydrochloride
|
Retanyx
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 July 2024
|
12 February 2025
|
| View |
|
DRP-11805-09
|
Co-Amoxiclav
|
Zebeclav
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/ Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd.
|
India
|
CLIDP Conversion
|
07 July 2024
|
05 May 2027
|
| View |
|
DRP-8985-11
|
Losartan Potassium
|
Zebesar
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
07 July 2024
|
21 July 2025
|
| View |
|
DRP-14026
|
Mometasone Furoate (As Monohydrate)
|
Modexa
|
50 mcg/actuation
|
Nasal Spray Suspension
|
Corticosteroid
|
Farmea
|
France
|
Initial
|
06 June 2023
|
06 June 2028
|
| View |
|
DRP-11290
|
Carbocisteine + Zinc
|
Docarb Plus
|
500mg / 5mg (equivalent to 13.72mg Zinc Sulfate
Monohydrate)
|
Film Coated Tablet
|
Mucolytic / Mineral
|
Phil. United Pharma Corp. (PUPC)
|
Philippines
|
Initial [OTC][Reissuance]
|
28 February 2022
|
22 November 2026
|
| View |
|
DRP-14042
|
Paracetamol + Tramadol Hydrochloride
|
None
|
325 mg/ 37.5 mg
|
Tablet
|
Analgesic/Antipyretic/Opioid Analgesic
|
Medico Remedies Limited
|
India
|
Initial
|
08 June 2023
|
08 June 2025
|
| View |
|
DRP-14339
|
Glycerin
|
Gvsoft
|
2 g
|
Rectal Suppository
|
Laxative
|
Bliss GVS Pharma Ltd. Unit II
|
India
|
Initial [OTC]
|
29 August 2023
|
29 August 2028
|
| View |
|
BRP-132-01
|
Trastuzumab
|
Valen
|
150 mg
|
Lyophilized Powder for Solution for Infusion (IV)
|
Monoclonal Antibodies
|
Reliance Life Sciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 July 2024
|
25 January 2029
|
| View |
|
BRP-132-02
|
Trastuzumab
|
Sadia
|
150 mg
|
Lyophilized Powder for Solution for Infusion (IV)
|
Monoclonal Antibodies
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
25 January 2029
|
| View |
|
DR-XY30021
|
Multivitamins + Minerals
|
Vitalux Plus
|
(see formulation)
|
Time Release Tablet
|
Vitamins/Minerals
|
Nutricorp International
|
Canada
|
CLIDP Conversion
|
08 July 2024
|
22 September 2029
|